Associate Director - Compound Market Access Leader

20h20 hours ago

Johnson & Johnson

Raritan, US · Full-time · $137,000 – $235,750

About this role

The Global Associate Director serves as Compound Market Access Leader within Johnson & Johnson's Global Commercial Strategy Organization. Reporting to the Senior Compound Market Access Leader for Early Pipeline & NBD, the role develops market access strategy for early oncology assets. It aligns with global clinical and commercial plans to shape decisions ahead of dedicated product teams.

Daily work includes directing cross-functional teams in Health Economics, Patient Reported Outcomes, Pricing, and Real-World Evidence. The leader integrates payer research and epidemiology data to build optimal value strategies. Strategic input ensures Clinical Development Plans meet market access requirements in key countries.

The position operates within an inclusive environment that respects individual merit and diversity across global teams. It serves as a thought partner to clinical, commercial, and disease area strategy leaders. Collaboration spans assets prior to full development investment and additional indications outside current remits.

Opportunities exist to evaluate New Business Development deals and maximize value through integrated access strategies. The role supports early planning of payer value generation from pre-transition stages through dedicated team appointment.

Requirements

Experience developing global market access strategy for pharmaceutical compounds and indications
Knowledge of Health Economics, PRO, Pricing, and Real-World Evidence functions
Ability to shape Clinical Development and Evidence Generation Plans for payer needs
Understanding of payer value propositions across early pipeline and NBD opportunities
Skill in supporting oncology assets prior to transition to full development teams

Responsibilities

Support the Sr CMAL and CMALs to maximize value across the early pipeline and NBD
Provide evaluation and strategic input into New Business Development opportunities to maximize deal value
Direct cross-functional teams across Health Economics, PRO, Access Policy, Pricing, and Real-World Evidence
Design and implement integrated approaches to payer value propositions from early development onward
Support early strategic planning and implementation of payer value generation and access strategies
Integrate pricing, payer research, health economic, and epidemiology information into value strategy
Serve as resource on access strategies for global clinical and commercial product teams